लोड हो रहा है...

High expression levels of erythropoietin and its receptor are not correlated with shorter survival in human glioblastoma

Erythropoietin (EPO) is used to treat anemia in neoplastic disease. EPO also exerts neuroprotective effects on neuronal cells, making a prophylactic use against the neurocognitive effects of radiochemotherapy probable. However, EPO/EPO-receptor (EPOR) signalling has been also detected in glioblastom...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: BRUNOTTE, J., BOCK, H.C., BRÜCK, W., HEMMERLEIN, B., STRIK, H.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: D.A. Spandidos 2011
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3440671/
https://ncbi.nlm.nih.gov/pubmed/22977501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2011.198
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!